MiAIRR data set / subset	MiAIRR field designation	Data type	Content format	MiAIRR content definition	Field value example	AIRR Formats WG field name
1 / study	Study	string	Free text	Unique ID assigned by study registry	PRJNA001	study_id
1 / study	Study title	string	Free text	Descriptive study title	Effects of sun light exposure of the Treg repertoire	study_title
1 / study	Study type	string	Controlled vocabulary	Generic study design	Placebo controlled phase 3 clinical trial	study_description
1 / study	Study inclusion/exclusion criteria	string	Free text	List of criteria for inclusion/exclusion for the study	Include: Clinical P. falciparum infection; Exclude: Seropositive for HIV	inclusion_exclusion_criteria
1 / study	Grant funding agency	string	Free text	Funding agencies and grant numbers	NIH, award number R01GM987654	grants
1 / study	Contact information (data collection)	string	Free text	Full contact information of the corresponding author, i.e. who is legally responsible for data collection and release. This should include an e-mail address.	p.stibbons@unseenu.edu	collected_by
1 / study	Lab name	string	Free text	Department of corresponding author	Stibbons Lab	lab_name
1 / study	Lab address	string	Free text	Institutional address of corresponding author	School of Medicine, Unseen University, Ankh-Morpork, Disk World	lab_address
1 / study	Contact information (data deposition)	string	Free text	Full contact information of the submitter, i.e. the person deposition the data	Dr. P. Stibbons	submitted_by
1 / study	Relevant publications	string	Valid PubMed ID	Publications describing the rationale and/or outcome of the study	PMID85642	pub_ids
1 / subject	Subject ID	string	Free text	Subject ID assigned by submitter, unique within study	SUB856413	subject_id
1 / subject	Synthetic library	boolean	TRUE/FALSE	TRUE for libraries in which the diversity has been synthetically generated (e.g. phage display)	FALSE	synthetic
1 / subject	Organism	string	Controlled vocabulary	Binomial designation of subject's species	Homo sapiens	organism
1 / subject	Sex	string	/(male|female|pooled|hermaphrodite|intersex|not collected|not applicable)/	Biological sex of subject	female	sex
1 / subject	Age	string	Time duration and unit	Absolute age of subject at time point `Age event`	65 a	age
1 / subject	Age event	string	Free text	Event in the study schedule to which `Age` refers to. For NCBI BioSample this MUST be `sampling`. For other implementations submitters need to be aware that there is currently no mechanism to encode to potential delta between `Age event` and `Sample collection time`, hence the chosen events should be in temporal proximity.	enrollment	age_event
1 / subject	Ancestry population	string	Free text	Broad geographic origin of ancestry (continent)	list of continents, mixed or unknown	ancestry_population
1 / subject	Ethnicity	string	Free text	Ethnic group of subject (defined as cultural/language-based membership)	English, Kurds, Manchu, Yakuts (and other fields from Wikipedia)	ethnicity
1 / subject	Race	string	Free text	Racial group of subject (as defined by NIH)	White, American Indian or Alaska Native, Black, Asian, Native Hawaiian or Other Pacific Islander, Other 	race
1 / subject	Strain name	string	Free text	Non-human: designation of the strain or breed of animal used	C57BL/6J	strain_name
1 / subject	Relation to other subjects	string	Free text	Subject ID to which `Relation type` refers to	SUB1355648	linked_subjects
1 / subject	Relation type	string	Free text	Relation between subject and `linked_subjects`, can be genetic or environmental (e.g.exposure)	father, daughter, household	link_type
1 / diag. & intervent.	Study group description	string	Free text	Designation of study arm to which the subject is assigned to	control	study_group_description
1 / diag. & intervent.	Diagnosis	string	Free text	Diagnosis of subject	Multiple myeloma	disease_diagnosis
1 / diag. & intervent.	Length of disease	string	Time duration and unit	Time duration between initial diagnosis and current intervention	23 months	disease_length
1 / diag. & intervent.	Disease stage	string	Free text	Stage of disease at current intervention	Stage II	disease_stage
1 / diag. & intervent.	Prior therapies for primary disease under study	string	Free text	List of all relevant previous therapies applied to subject for treatment of `Diagnosis`	melphalan/prednisone	prior_therapies
1 / diag. & intervent.	Immunogen/agent	string	Free text	Antigen, vaccine or drug applied to subject at this intervention	bortezomib	immunogen
1 / diag. & intervent.	Intervention definition	string	Free text	Description of intervention	systemic chemotherapy, 6 cycles, 1.25 mg/m2	intervention
1 / diag. & intervent.	Other relevant medical history	string	Free text	Medical history of subject that is relevant to assess the course of disease and/or treatment	MGUS, first diagnosed 5 years prior	medical_history
2 / sample	Biological sample ID	string	Free text	Sample ID assigned by submitter, unique within study	SUP52415	sample_id
2 / sample	Sample type	string	Free text	The way the sample was obtained, e.g. fine-needle aspirate, organ harvest, peripheral venous puncture	Biopsy	sample_type
2 / sample	Tissue	string	Free text	The actual tissue sampled, e.g. lymph node, liver, peripheral blood	Bone marrow	tissue
2 / sample	Anatomic site	string	Free text	The anatomic location of the tissue, e.g. Inguinal, femur	Iliac crest	anatomic_site
2 / sample	Disease state of sample	string	Free text	Histopathologic evaluation of the sample	Tumor infiltration	disease_state_sample
2 / sample	Sample collection time	string	Free text	Time point at which sample was taken, relative to `Collection time event`	14 d	collection_time_point_relative
2 / sample	Collection time event	string	Free text	Event in the study schedule to which `Sample collection time` relates to	Primary vaccination	collection_time_point_reference
2 / sample	Biomaterial provider	string	Free text	Name and address of the entity providing the sample	Tissues-R-Us, Tampa, FL, USA	biomaterial_provider
3 / process (cell)	Tissue processing	string	Free text	Enzymatic digestion and/or physical methods used to isolate cells from sample	Collagenase A/Dnase I digested, followed by Percoll gradient	tissue_processing
3 / process (cell)	Cell subset	string	Controlled vocabulary	Commonly-used designation of isolated cell population	Class-switched Memory B cells	cell_subset
3 / process (cell)	Cell subset phenotype	string	Free text	List of cellular markers and their expression levels used to isolate the cell population	CD19+ CD38+ CD27+ IgM- IgD-	cell_phenotype
3 / process (cell)	Single-cell sort	boolean	TRUE/FALSE	TRUE if single cells were isolated into separate compartments	FALSE	single_cell
3 / process (cell)	Number of cells in experiment	integer	Number	Total number of cells that went into the experiment	1000000	cell_number
3 / process (cell)	Number of cells per sequencing reaction	integer	Number	Number of cells for each biological repicate	50000	cells_per_reaction
3 / process (cell)	Cell storage	boolean	TRUE/FALSE	TRUE if cells were cryo-preserved between isolation and further processing	TRUE	cell_storage
3 / process (cell)	Cell quality	string	Free text	Relative amount of viable cells after preparation and (if applicable) thawing	90% viability as determined by 7-AAD	cell_quality
3 / process (cell)	Cell isolation / enrichment procedure	string	Free text	Description of the procedure used for marker-based isolation or enrich cells	Cells were stained with fluorochrome labeled antibodies and then sorted on a FlowMerlin (CE) cytometer	cell_isolation
3 / process (cell)	Processing protocol	string	Free text	Description of the methods applied to the sample including cell preparation/ isolation/enrichment and nucleic acid extraction. This should closely mirror the Materials and methods section in the manuscript	Stimulated wih anti-CD3/anti-CD28	cell_processing_protocol
3 / process (nucl. acid)	Target substrate	string	/(DNA|RNA)/	The class of nucleic acid that was used as primary starting material for the following procedures	RNA	template_class
3 / process (nucl. acid)	Target substrate quality	string	Free text	Description and results of the quality control performed on the template material	RIN 9.2	template_quality
3 / process (nucl. acid)	Template amount	string	Free text	Amount of template that went into the process	1000 ng	template_amount
3 / process (nucl. acid)	Library generation method	string	Controlled vocabulary	Generic type of library generation	Oligo-dT primed 5' RACE	library_generation_method
3 / process (nucl. acid)	Library generation protocol	string	Free text	Description of processes applied to substrate to obtain a library that is ready for sequencing	cDNA was generated using	library_generation_protocol
3 / process (nucl. acid)	Protocol IDs	string	Free text	When using a library generation protocol from a commercial provider, provide the protocol version number	v2.1 (2016-09-15)	library_generation_kit_version
3 / process (nucl. acid)	Target locus for PCR	string	Free text	Designation of the target locus according to standard gene nomencleature	Constant region vs. V region amplification	pcr_target_locus
3 / process (nucl. acid)	Forward PCR primer target location	string	Free text	Position of the most distal nucleotide templated by the forward primer or primer mix	IGHV, +23	forward_pcr_primer_target_location
3 / process (nucl. acid)	Reverse PCR primer target location	string	Free text	Position of the most proximal nucleotide templated by the reverse primer or primer mix	IGHG, +57	reverse_pcr_primer_target_location
3 / process (nucl. acid)	Complete sequences	string	/(partial|complete|complete+untemplated)/	To be considered `complete`, the procedure used for library construction MUST generate sequences that 1) include the first V segment codon that encodes the mature polypeptide chain (i.e. after the leader sequence) and 2) include the last complete codon of the J segment (i.e. 1 bp 5' of the J->C splice site) and 3) provide sequence information for all positions between 1) and 2). To be considered `complete & untemplated`, the sections of the sequences defined in points 1) to 3) of the previous sentence MUST be untemplated, i.e. MUST NOT overlap with the primers used in library preparation.	partial	complete_sequences
3 / process (nucl. acid)	Physical linkage of different loci	string	Controlled vocabulary	Describes the mode of linkage if a method was used which physically links nucleic acids derived from distinct loci in a single-cell context	IGH-IGK/IGL-head/head	physical_linkage
3 / process (sequencing)	Total reads passing QC filter	integer	Number	Number of usable reads for analysis	10365118	total_reads_passing_qc_filter
3 / process (sequencing)	Sequencing platform	string	Free text	Designation of sequencing instrument used	Alumina LoSeq 1000	sequencing_platform
3 / process (sequencing)	Read lengths	integer	Array of numbers	Read length in bases for each direction	[300,300]	read_length
3 / process (sequencing)	Sequencing facility	string	Free text	Name and address of sequencing facility	Seqs-R-Us, Vancouver, BC, Canada	sequencing_facility
3 / process (sequencing)	Batch number	string	Free text	ID of sequencing run assigned by the sequencing facility	160101_M01234_0201_000000000-D2T7V	sequencing_run_id
3 / process (sequencing)	Date of sequencing run	string	ISO8601-compliant date	Date of sequencing run	2016-12-16	sequencing_run_date
3 / process (sequencing)	Sequencing kit	string	Free text	Name, manufacturer, order and lot numbers of sequencing kit	FullSeq 600, Alumina, #M123456C0, 789G1HK	sequencing_kit
4 / data (raw reads)	Raw sequence data		FASTQ	Sequence and quality score of all passing reads	<n/a>	
5 / process (comput.)	Software tools and version numbers	string	Free text	Version number and / or date, include company pipelines	IgBLAST 1.6	software_versions
5 / process (comput.)	Paired read assembly	string	Free text	How paired end reads were assembled into a single receptor sequence	PandaSeq (minimal overlap 50, threshold 0.8)	paired_reads_assembly
5 / process (comput.)	Quality thresholds	string	Free text	How sequences were removed from (4) based on base quality scores		quality_thresholds
5 / process (comput.)	Primer match cutoffs	string	Free text	How primers were identified in the sequences, were they removed/masked/etc?		primer_match_cutoffs
5 / process (comput.)	Collapsing method	string	Free text	The method used for combining multiple sequences from (4) into a single sequence in (5)	MUSCLE 3.8.31	collapsing_method
5 / process (comput.)	Data processing protocols	string	Free text	General description of how QC is performed		data_processing_protocols
6 / data (proc. seq.)	V(D)J germline reference database	string	Free text	Databases used for VDJC gene annotation plus date of retrieval / version	ENSEMBL, Homo sapiens build 90, 2017-10-01	germline_database
6 / data (proc. seq.)	Cell Index	string	Free text	User-specified ID for the cell from which the sequence was obtained	W06_046_091	cell_id
6 / data (proc. seq.)	V gene	string	Free text	V segment gene and allele	IGHV1-34*01	v_call
6 / data (proc. seq.)	D gene	string	Free text	D segment gene and allele	IGHD2-2*01	d_call
6 / data (proc. seq.)	J gene	string	Free text	J segment gene and allele	IGHJ4*01	j_call
6 / data (proc. seq.)	C region	string	Free text	Constant region gene and allele	IGHG1	c_call
6 / data (proc. seq.)	IMGT-JUNCTION nucleotide sequence	string	Free text	Nucleotide sequence of the IMGT-JUNCTION	TGTGCAAGAGCGGGAGTTTACGACGGATATACTATGGACTACTGG	junction
6 / data (proc. seq.)	IMGT-JUNCTION amino acid sequence	string	Free text	Amino acid sequence of the IMGT-JUNCTION	CARAGVYDGYTMDYW	junction_aa
6 / data (proc. seq.)	Read count	integer	Number	Number of reads used to build sequence	123	duplicate_count
